Author Archives: Natalie Themm
R-Zero Raises $105 Million Series C to Improve the Indoor Air We Breathe
R-Zero’s UV-C Technology Improves Indoor Air Quality for Millions of People; Reduces Reliance on HVAC Systems and Chemicals that Harm Environment
SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational
Facility will produce high-performance ceramic armor products for personnel, aircraft, and vehicles
SINTX Technologies Announces Closing of $12.0 Million Public Offering
SINTX Technologies Announces Closing of $12.0 Million Public Offering
US FDA 510(k) Clearance and CLIA-waiver for the fast and innovative BIOFIRE® SPOTFIRE® System and its BIOFIRE® SPOTFIRE® Respiratory (R) Panel
US FDA 510(k) Clearance and CLIA-waiver for the fast and innovative BIOFIRE® SPOTFIRE® System
Renalytix announces a c.$20.3 million private placement
Renalytix announces a c.$20.3 million private placement
Quansys Biosciences launches new NHP line of Multiplex ELISA Assays
NHP-specific ELISAs now available from Quansys Biosciences
DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease
DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease
POSITIVE TWO-YEAR CLINICAL DATA ANNOUNCED FOR STUDY OF DISCOGENIC PROGENITOR CELL THERAPY (IDCT) FOR DEGENERATIVE DISC DISEASE
POSITIVE TWO-YEAR CLINICAL DATA ANNOUNCED FOR STUDY OF DISCOGENIC PROGENITOR CELL THERAPY (IDCT) FOR DEGENERATIVE DISC DISEASE
Renalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United States
Award for consortium of industry, academic and clinical research leaders to develop personalized drug response tests in chronic kidney disease
Halia Therapeutics Appoints Former Amgen Executive, Margit M. Janát-Amsbury, MD, Ph.D., as Chief Medical Officer
Halia Therapeutics announced the appointment of Dr. Margit M. Janát-Amsbury, MD, Ph.D. as the company’s Chief Medical Officer
Advanced Practice Clinical Laboratory Training Center at ARUP Secures $3 Million in Federal Funding
ARUP Laboratories and the University of Utah’s Division of Medical Laboratory Sciences have secured $3 million in federal funding.
Inherent Biosciences Partners With Posterity Health to Accelerate the Path to Parenthood by Elevating the Standard of Care in Male Reproductive Health
Inherent Biosciences has teamed up with Posterity Health, the only virtual Male Fertility Center of Excellence, to address male fertility
